ArticleProceedings of the National Academy of Sciences of the United States of America2022

Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target.

Insha Zahoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.